FH.NE Filament Health (NEO) C$0.01 in market hours: Oversold bounce setup
Filament Health Corp. (FH.NE) trades at C$0.01 in market hours on 21 Jan 2026, marking a one-day drop of -33.33%. The sharp move leaves FH.NE stock deeply oversold versus its 50-day average of C$0.02 and 200-day average of C$0.03. Volume at 929,483 shares signals active selling but also creates a clearing condition for a short-term bounce. We outline a tactical oversold bounce strategy for traders on the NEO exchange in Canada, tying technical levels to fundamentals, price targets, and risk controls.
Quick snapshot and market context
Filament Health Corp. (FH.NE) is listed on the NEO exchange in Canada and operates in Healthcare. Current price is C$0.01 with market cap C$3,926,910 and 392,691,000 shares outstanding. Intraday range today was C$0.005–C$0.015 and year range is C$0.005–C$0.07. Average volume is 4,885,995; today’s trade of 929,483 shows below-average liquidity but above normal activity for the recent downtrend.
Technical read: oversold levels and bounce signals
FH.NE stock sits well below moving averages: 50-day C$0.02 and 200-day C$0.03, creating an oversold condition in market hours. The price collapse has pushed momentum indicators toward extreme readings that historically precede short-term rebounds in micro-cap healthcare names. Traders can watch a bounce attempt above C$0.015 for initial strength and C$0.03 as a more reliable recovery level.
Meyka grade and what it means for traders
Meyka AI rates FH.NE with a score out of 100: 57.72/100, Grade C+, Suggestion: HOLD. This grade factors S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. The C+ reflects weak financials but potential event-driven upside. Meyka AI provides this as informational, not financial advice.
Fundamentals and valuation checks
Filament Health shows negative earnings with EPS -0.02 and a distorted PE -0.50. Price-to-book is 1.50 while current ratio is 0.44, indicating short-term liquidity pressure. Price-to-sales stands at 12.57, reflecting very low revenue per share of C$0.00 (rounded). Debt to equity is modest at 0.15 but cash per share is only C$0.00 to two decimals. The fundamentals support a speculative classification and heighten execution risk for an oversold bounce trade.
Catalysts, news and sector context
Key near-term events include an earnings announcement scheduled for 2025-03-31 and any R&D updates. The healthcare sector has lagged year-to-date; Filament’s small size makes it sensitive to biotech sentiment. For competitor comparisons and analyst notes see investing.com coverage for Filament and peers source and additional regional commentary source. Also view the Meyka stock page for live indicators and alerts Filament FH.NE on Meyka.
Trade plan: oversold bounce strategy and price targets
Setup: Enter on a confirmed intraday reversal above C$0.015 with volume pickup. Initial target: C$0.03; secondary target: C$0.05. Stop: tight at C$0.005 to limit downside. Position sizing should cap risk to 1–2% of portfolio on speculative micro-cap plays. Use limit orders and avoid holding through major announcements.
Final Thoughts
Key takeaway: FH.NE stock is deeply oversold in market hours on 21 Jan 2026, trading at C$0.01 after a -33.33% drop. The combination of heavy relative selling, low liquidity, and stretched technicals creates a short-term bounce opportunity for tactical traders who accept high risk. Meyka AI’s forecast model projects a short-term bounce to C$0.03 and a 12-month scenario to C$0.05 versus the current C$0.01, implying projected upside of +200.00% and +400.00% respectively. Forecasts are model-based projections and not guarantees. Given weak fundamentals—EPS -0.02, current ratio 0.44, price-to-sales 12.57—this is a high-volatility, event-driven trade best sized small. Monitor volume above 929,483 and any R&D or earnings news as triggers for the next leg. Use clear stops at C$0.005 and reassess on any close above C$0.03.
FAQs
Is FH.NE stock a buy after the drop?
FH.NE stock is speculative after the fall to C$0.01. Traders seeking an oversold bounce may enter small positions above C$0.015 with tight stops. Long-term buyers should wait for revenue growth and liquidity improvement.
What are sensible price targets for FH.NE stock?
A tactical bounce target is C$0.03 and a longer 12-month scenario is C$0.05. These targets come from pattern recovery and model scenarios. All targets are projections, not guarantees.
How does the Meyka grade affect FH.NE stock outlook?
Meyka AI rates FH.NE with a score out of 100: 57.72, Grade C+ and suggestion HOLD. The grade balances sector and financial metrics and flags the stock as speculative for tactical trades.
What risks should traders watch for with FH.NE stock?
Main risks: low liquidity, weak current ratio 0.44, high price volatility, and limited revenue. News around R&D or financing can move the stock sharply. Use stops and small position sizes.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
